 Activity clarithromycin Mycobacterium avium infection patients immune deficiency syndrome controlled clinical trial Disseminated Mycobacterium avium infection common patients immune deficiency syndrome AIDS drug studies antimicrobial activity organism trial Clarithromycin new macrolide activity avium vitro animals humans randomized double-blind placebo-controlled trial ability clarithromycin avium bacteremia patients AIDS infection patients men late-stage AIDS study group clarithromycin wk rifampin isoniazid ethambutol clofazimine wk group drugs units CFU avium milliliter blood quantitative cultures baseline wk Minimum inhibitory concentration clarithromycin strains patients baseline agar pH micrograms/ml Eight eligible patients initial positive cultures declines blood avium CFU cases CFU zero patients drugs CFU patients undetectable eligible patients placebo progressive CFU increases drugs CFU